Soluble receptor for advanced glycation end products (sRAGE) in tracheobronchial aspirate fluid and cord blood of very low birth weight infants with chorioamnionitis and funisitis

Early Human Development

Volumn 86, Issue 9, 2010, Pages 593-598

  Thomas, Wolfgang ^a   Seidenspinner, Silvia ^a   Kawczyńska Leda, Natalia ^b   Wirbelauer, Johannes ^a   Szymankiewicz, Marta ^b   Speer, Christian P ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Advanced glycosylation end product receptor; Bronchopulmonary dysplasia; Lung injury; Premature infant

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCT; STEROID; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION; BRONCHUS; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HISTOLOGY; HUMAN; HUMAN TISSUE; INFANT; INFLAMMATION; LUNG DYSPLASIA; MALE; OXYGEN THERAPY; PLACENTA; PREMATURITY; TRACHEA; UMBILICAL CORD BLOOD; VERY LOW BIRTH WEIGHT;

BODY FLUIDS; CHORIOAMNIONITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; PREGNANCY; RECEPTORS, IMMUNOLOGIC;

EID: 77956322108     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.07.013     Document Type: Article

References (42)

1. Chavakis T., Bierhaus A., Nawroth P.P. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 2004, 6:1219-1225.
2. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005, 83:876-886.
3. Sims G.P., Rowe C.D., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010, 28:367-388.
4. Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003, 198:1507-1515.
5. Bopp C., Bierhaus A., Hofer S., Boucheon A., Nawroth P.P., Martin E., et al. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as therapeutic target in sepsis. Crit Care 2008, 12:201. (doi:10.1186/cc6164).
6. Hudson B.I., Carter A.M., Harja E., Kalea A.Z., Arriero M., Yang H., et al. Identification, classification and expression of RAGE gene splice products. FASEB J 2008, 22:3716-3727.
7. Hudson B.I., Harja E., Moser B., Schmidt A.M. Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?. Arterioscler Thromb Vasc Biol 2005, 25:879-882.
8. Santilli F., Vazzana N., Bucciarelli L.G., Davi G. Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem 2009, 16:940-952.
9. Fehrenbach H., Kasper M., Tschernig T., Shearman M.S., Schuh D., Muller M. Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. Cell Mol Biol 1998, 44:1147-1157.
10. Shirasawa M., Fujiwara N., Hirabayashi S., Ohno H., Iida J., Makita K., et al. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 2004, 9:165-174.
11. Katsuoka F., Kawakami Y., Arai T., Imuta H., Fujiwara M., Kanma H., et al. Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene. Biochem Biophys Res Commun 1997, 238:512-516.
12. Lizotte P.P., Hanford L.E., Enghild J.J., Nozik-Grayck E., Giles B.L., Oury T.D. Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev Biol 2007, 7:15.
13. Mukherjee T.K., Mukhopadhyay S., Hoidal J.R. Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol 2008, 162:210-215.
14. Zhang H., Tasaka S., Shiraishi Y., Fukunaga K., Yamada W., Seki H., et al. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 2008, 178:356-362.
15. Sternberg D.I., Gowda R., Mehra D., Qu W., Weinberg A., Twaddell W., et al. Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice. J Thorac Cardiovasc Surg 2008, 136:1576-1585.
16. Uchida T., Shirasawa M., Ware L.B., Kojima K., Hata Y., Makita K., et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006, 173:1008-1015.
17. Lindstrom T.M., Bennett P.R. The role of nuclear factor kappa B in human labour. Reproduction 2005, 130:569-581.
18. Romero R., Espinoza J., Hassan S., Gotsch F., Kusanovic J.P., Avila C., et al. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. J Perinat Med 2008, 36:388-398.
19. Buhimschi I.A., Zhao G., Pettker C.M., Bahtiyar M.O., Magloire L.K., Thung S., et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol 2007, 196(181):e1-13.
20. Hajek Z., Germanova A., Koucky M., Zima T., Kopecky P., Vitkova M., et al. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. J Perinat Med 2008, 36:399-404.
21. Pacora P., Chaiworapongsa T., Maymon E., Kim Y.M., Gomez R., Yoon B.H., et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Mater Fetal Neonatal Med 2002, 11:18-25.
22. D'Alquen D., Kramer B.W., Seidenspinner S., Marx A., Berg D., Groneck P., Speer C.P. Activation of umbilical cord endothelial cells and fetal inflammatory response in preterm infants with chorioamnionitis and funisitis. Pediatr Res 2005, 57:263-269.
23. Yoon B.H., Romero R., Park J.S., Kim M., Oh S.Y., Kim C.J., et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000, 183:1124-1129.
24. Yoon B.H., Romero R., Kim K.S., Park J.S., Ki S.H., Kim B.I., et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999, 181:773-779.
25. Matsuda T., Nakajima T., Hattori S., Hanatani K., Fukazawa Y., Kobayashi K., et al. Necrotizing funisitis: clinical significance and association with chronic lung disease in premature infants. Am J Obstet Gynecol 1997, 177:1402-1407.
26. Lau J., Magee F., Qiu Z., Hoube J., Von Dadelszen P., Lee S.K. Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response only. Am J Obstet Gynecol 2005, 193:708-713.
27. Buhimschi C.S., Baumbusch M.A., Dulay A.T., Oliver S.L., Zhao G., Bhandari V., et al. Characterization of RAGE, HMGB1 and S100ß in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol 2009, 175:958-975.
28. Rogers B.B., Alexander J.M., Head J., McIntire D., Leveno K.J. Umbilical vein interleukin-6 levels correlate with the severity of placental inflammation and gestational age. Hum Pathol 2002, 33:335-340.
29. Watts C.L., Bruce M.C. Comparison of secretory component for immunoglobulin A with albumin as reference proteins in tracheal aspirate from preterm infants. J Pediatr 1995, 127:113-122.
30. Groneck P., Gotze-Speer B., Oppermann M., Eiffert H., Speer C.P. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994, 93:712-718.
31. Speer C.P. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009, 95:353-361.
32. Wirbelauer J., Schmidt B., Klingel K., Cao L., Lang F., Speer C.P. Serum and glucocorticoid-inducible kinase in pulmonary tissue of preterm fetuses exposed to chorioamnionitis. Neonatology 2008, 93:257-262.
33. Liliensiek B., Weigand M.A., Bierhaus A., Nicklas W., Kasper M., Hofer S., et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004, 113:1641-1650.
34. Bopp C., Hofer S., Weitz J., Bierhaus A., Nawroth P.P., Martin E., et al. sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008, 147:79-83.
35. Schmidt B., Cao L., Mackensen-Haen S., Kendziorra H., Klingel K., Speer C.P. Chorioamnionitis and inflammation of the fetal lung. Am J Obstet Gynecol 2001, 185:173-177.
36. Kramer B.W., Kramer S., Ikegami M., Jobe A.H. Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin. Am J Physiol Lung Cell Mol Physiol 2002, 283:L452-L459.
37. Kramer B.W., Ladenburger A., Kunzmann S., Speer C.P., Been J.V., van Iwaarden J.F., et al. Intravenous lipopolysaccharide-induced pulmonary maturation and structural changes in fetal sheep. Am J Obstet Gynecol 2009, 200(195):e1-10.
38. Kramer B.W., Ikegami M., Moss T.J., Nitsos I., Newnham J.P., Jobe A.H. Endotoxin- induced chorioamnionitis modulates innate immunity of monocytes in preterm sheep. Am J Respir Crit Care Med 2005, 171:73-77.
39. Kramer B.W., Kallapur S.G., Moss T.J., Nitsos I., Newnham J.P., Jobe A.H. Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep. Innate Immun 2009, 15:101-107.
40. Aneja R.K., Tsung A., Sjodin H., Gefter J.V., Delude R.L., Billiar T.R., et al. Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. J Leukoc Biol 2008, 84:1326-1334.
41. Aghai Z.H., Saslow J.G., Meniru C., Porter C., Eydelman R., Bhat V., et al. High mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy. J Perinatol advance online publication 25 Feb 2010, (doi:10.1038/jp2010.16).
42. Lemons J.A., Bauer C.R., Oh W., Korones S.B., Papile L.A., Stoll B.J., et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatric 2001, 107:E1.